z-logo
open-access-imgOpen Access
Immune imprinting, breadth of variant recognition, and germinal center response in human SARS-CoV-2 infection and vaccination
Author(s) -
Katharina Röltgen,
Sandra C. A. Nielsen,
Oscar Silva,
Sheren Younes,
Maxim Zaslavsky,
Cristina Costales,
Fan Yang,
Oliver F. Wirz,
Daniel Solis,
Ramona A. Hoh,
Aihui Wang,
Prabhu S. Arunachalam,
Deana R.C. Colburg,
Shuchun Zhao,
Emily Haraguchi,
Alexandra S. Lee,
Mihir Shah,
Monali Manohar,
Iris Chang,
Fei Gao,
Vamsee Mallajosyula,
Chunfeng Li,
James Liu,
Massa J. Shoura,
Sayantani Sindher,
Ella Parsons,
Naranjargal Dashdorj,
Naranbaatar Dashdorj,
R. J. Monroe,
Geidy E. Serrano,
Thomas G. Beach,
R. Sharon Chinthrajah,
Gregory W. Charville,
James L. Wilbur,
Jacob N. Wohlstadter,
Mark M. Davis,
Bali Pulendran,
Megan L. Troxell,
George B. Sigal,
Yasodha Natkunam,
Benjamin A. Pinsky,
Kari C. Nadeau,
Scott D. Boyd
Publication year - 2022
Publication title -
cell
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 26.304
H-Index - 776
eISSN - 1097-4172
pISSN - 0092-8674
DOI - 10.1016/j.cell.2022.01.018
Subject(s) - germinal center , biology , vaccination , serology , virology , immune system , immunology , antibody , antigen , b cell
During the SARS-CoV-2 pandemic, novel and traditional vaccine strategies have been deployed globally. We investigated whether antibodies stimulated by mRNA vaccination (BNT162b2), including third-dose boosting, differ from those generated by infection or adenoviral (ChAdOx1-S and Gam-COVID-Vac) or inactivated viral (BBIBP-CorV) vaccines. We analyzed human lymph nodes after infection or mRNA vaccination for correlates of serological differences. Antibody breadth against viral variants is lower after infection compared with all vaccines evaluated but improves over several months. Viral variant infection elicits variant-specific antibodies, but prior mRNA vaccination imprints serological responses toward Wuhan-Hu-1 rather than variant antigens. In contrast to disrupted germinal centers (GCs) in lymph nodes during infection, mRNA vaccination stimulates robust GCs containing vaccine mRNA and spike antigen up to 8 weeks postvaccination in some cases. SARS-CoV-2 antibody specificity, breadth, and maturation are affected by imprinting from exposure history and distinct histological and antigenic contexts in infection compared with vaccination.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom